T-Cell Lymphoma Clinical Trials

A listing of T-Cell Lymphoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 175 clinical trials
GPED Regimen for Relapsed/Refractory or Advanced ENKTCL

The purpose of this study is to evaluate the efficacy and safety of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in the treatment of Relapsed/Refractory or advanced NK/T-cell

  • 03 Jun, 2020
  • 1 location
Camrelizumab Pegaspargase and Apatinib With Radiation Therapy for Stage IE/IIE ENKTL

patients with de novo stage IE/IIE extranodal natural killer/T-cell lymphoma, nasal type.

  • 07 May, 2020
PEG-ASP Etoposide and Gemcitabine for Natural Killer/T Lymphoma

Extranodal natural killer/T-cell lymphoma (ENKTL) is an aggressive form of non-Hodgkin's lymphoma and shows extremely poor survival. This prospective pilot study to evaluate the efficacy and

  • 27 Dec, 2020
  • 2 locations
Sintilimab in Combination With Chidamide in Refractory and Relapsed ENKTCL

Extranodal natural killer/T cell lymphoma(ENKTCL) is a distinct lymphoid neoplasm with aggressive course and poor outcomes. Optimal treatment strategies for advanced ENKTCL have not been fully

  • 16 Mar, 2020
  • 4 locations
Chidamide Combined With VDDT Regimen in the Relapse and Refractory Diffuse Large B Cell Lymphoma

This is a prospective phase II clinical trial to observe the efficacy and safety of Chidamide combined with VDDT(vinorelbineliposomal doxorubicindexamethasone and thalidomide) in relapsed and refractory patients with diffuse large B-cell lymphoma(DLBCL).

b-cell lymphoma
neutrophil count
  • 09 Apr, 2020
  • 1 location
Chidamide With Immunotherapy for Patients With Locally Advanced or Metastatic Urothelial Carcinoma

Study of Chidamide Combined With Immunotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Who Had Previously Received Platinum-based Chemotherapy

  • 18 Oct, 2020
  • 1 location
The WWRD Study: AVM0703 for Treatment of Leukemia or Lymphoma

This is an open-label, Phase 1/2 study designed to characterize the safety, tolerability, Pharmacokinetics(PK), and preliminary antitumor activity of AVM0703 administered as a single intravenous (IV) infusion to patients with lymphoid malignancies.

  • 05 Jan, 2021
  • 3 locations
IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

This is an open label, multi-cohort, and multi-center phase II study, which evaluates the clinical activity and safety of IPH4102 in Sezary Syndrome and Mycosis fungoides as single agent.

skin lesion
neutrophil count
ct scan
  • 21 Nov, 2020
  • 36 locations
A Study of Duvelisib in Patients With Relapsed or Refractory Peripheral T Cell Lymphoma (PTCL)

This is a multi-center, parallel cohort, open-label, Phase 2 study of duvelisib, an oral dual inhibitor of PI3K-,, in patients with relapsed or refractory Peripheral T cell Lymphoma (PTCL

measurable disease
anaplastic large cell lymphoma
t-cell lymphoma
angioimmunoblastic t-cell lymphoma
large cell lymphoma
  • 08 Oct, 2020
  • 28 locations
Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides

This is a phase II study to evaluate the antitumor activity and safety of AFM13 given as monotherapy in patients with CD30-positive T-cell lymphoma. The investigational medicinal product AFM13

mycosis fungoides
ct scan
anaplastic large cell lymphoma
systemic therapy
  • 11 Dec, 2020
  • 73 locations